In silico Discovery of Novel FXa Inhibitors by Pharmacophore Modeling and Molecular Docking

被引：4

作者：

Pu Y. ^{[1
]}

Liu H. ^{[1
]}

Zhou Y. ^{[1
]}

Peng J. ^{[1
]}

Li Y. ^{[1
]}

Li P. ^{[1
]}

Li Y. ^{[1
]}

Liu X. ^{[1
]}

Zhang L. ^{[1
]}

机构：

[1] School of Chemical Engineering, Sichuan University of Science & Engineering, Zigong

来源：

Natural Products and Bioprospecting | 2017年 / 7卷 / 3期

关键词：

Docking; FXa; Pharmacophore; Thrombotic diseases;

D O I：

10.1007/s13659-017-0126-x

中图分类号：

学科分类号：

摘要：

Abstract: Coagulation Factor Xa (FXa) is the crucial enzyme at the convergent point of the intrinsic and extrinsic coagulation pathways. The inhibition of FXa is an effective approach against thrombotic diseases. In the present study, a specific strategy is reported to discover 10 novel FXa inhibitors based on ligand-based (pharmacophore) virtual screening and molecular docking analysis from a dataset of specs(containing 220000 molecules). The binding modes analysis provide insights into the contribution of particular structural moieties of the compounds towards their activity against FXa, and 10 novel structural compounds were discovered as potent candidate molecules. This work could be helpful in further design and development of FXa inhibitors. Graphical Abstract: [Figure not available: see fulltext.]. © 2017, The Author(s).

引用

页码：249 / 256

页数：7

共 50 条

[1] Novel Isosteviol-Based FXa Inhibitors: Molecular Modeling, In Silico Design and Docking Simulation
Gackowski, Marcin
Madriwala, Burhanuddin
Studzinska, Renata
Koba, Marcin
[J]. MOLECULES, 2023, 28 (13):
[2] In silico approaches using pharmacophore model combined with molecular docking for discovery of novel ULK1 inhibitors
He, Siyu
Liu, Yang
Li, Qihang
Lyu, Weiping
Feng, Feng
Guo, Qinglong
Zhao, Li
Sun, Haopeng
[J]. FUTURE MEDICINAL CHEMISTRY, 2021, 13 (04) : 341 - 361
[3] Pharmacophore modeling, virtual screening, and molecular docking studies for discovery of novel Carbonic anhydrase IX inhibitors
Lu, Chun-Lin
Zhou, Lu
Li, Zi-Cheng
Gao, Xiang
Zhang, Wei
[J]. MEDICINAL CHEMISTRY RESEARCH, 2012, 21 (11) : 3417 - 3427
[4] Pharmacophore modeling, virtual screening, and molecular docking studies for discovery of novel Carbonic anhydrase IX inhibitors
Chun-Lin Lu
Lu Zhou
Zi-Cheng Li
Xiang Gao
Wei Zhang
[J]. Medicinal Chemistry Research, 2012, 21 : 3417 - 3427
[5] Pharmacophore Modeling, Virtual Screening, and Molecular Docking Studies for Discovery of Novel Akt2 Inhibitors
Fei, Jia
Zhou, Lu
Liu, Tao
Tang, Xiang-Yang
[J]. INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2013, 10 (03): : 265 - 275
[6] The Discovery of Novel ß-Secretase Inhibitors: Pharmacophore Modeling, Virtual Screening, and Docking Studies
Niu, Yan
Ma, Chao
Jin, Hongwei
Xu, Fengrong
Gao, Haifei
Liu, Peng
Li, Yongjian
Wang, Chao
Yang, Guanyu
Xu, Ping
[J]. CHEMICAL BIOLOGY & DRUG DESIGN, 2012, 79 (06) : 972 - 980
[7] In silico Screening for Identification of Novel Anti-malarial Inhibitors by Molecular Docking, Pharmacophore Modeling and Virtual Screening
Batool, Sidra
Khan, Zeshan Aslam
Kamal, Warda
Mushtaq, Gohar
Kamal, Mohammad Amjad
[J]. MEDICINAL CHEMISTRY, 2015, 11 (07) : 687 - 700
[8] Molecular Docking Study Based on Pharmacophore Modeling for Novel PhosphodiesteraseIV Inhibitors
Cifci, Gulsah
Aviyente, Viktorya
Akten, E. Demet
[J]. MOLECULAR INFORMATICS, 2012, 31 (6-7) : 459 - 471
[9] In Silico Exploration of Novel Tubulin Inhibitors: A Combination of Docking and Molecular Dynamics Simulations, Pharmacophore Modeling, and Virtual Screening
Hadizadeh, Farzin
Ghodsi, Razieh
Mirzaei, Salimeh
Sahebkar, Amirhossein
[J]. COMPUTATIONAL AND MATHEMATICAL METHODS IN MEDICINE, 2022, 2022
[10] Discovery of novel inhibitors of 11β-hydroxysteroid dehydrogenase type 1 by docking and pharmacophore modeling
Yang, Huaiyu
Dou, Wei
Lou, Jing
Leng, Ying
Shen, Jianhua
[J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (04) : 1340 - 1345

← 1 2 3 4 5 →